(Q47773433)

5 February 2018

title

Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response (English)

1 reference

5 February 2018

0 references

Pneumocystis carinii

1 reference

Theus SA

1

1 reference

5 February 2018

Smulian AG

2

1 reference

5 February 2018

Steele P

3

1 reference

5 February 2018

Linke MJ

4

1 reference

5 February 2018

Walzer PD

5

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

5 February 2018

published in

Vaccine

1 reference

5 February 2018

volume

16

1 reference

5 February 2018

issue

11-12

1 reference

5 February 2018

page(s)

1149-1157

1 reference

5 February 2018

Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

A tandem repeat of rat-derived Pneumocystis carinii genes encoding the major surface glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Antigenic variation by positional control of major surface glycoprotein gene expression in Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Isolation and characterization of a recombinant antigen of Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Purification and characterization of a major human Pneumocystis carinii surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Cytokine responses to the native and recombinant forms of the major surface glycoprotein of Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Pneumocystis carinii is resistant to imidazole antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Cytokine regulation of T-cell function: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Interleukin-4 and -10 exacerbate candidiasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Pneumocystis carinii osteomyelitis in a patient with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

The interaction in vitro of Pneumocystis carinii with macrophages and L-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Progress towards an amebiasis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2980113-8

7 January 2021

10.1016/S0264-410X(98)80113-8

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018